tiprankstipranks
Acro Biomedical Co Ltd (ACBM)
OTHER OTC:ACBM
US Market
Holding ACBM?
Track your performance easily

Acro Biomedical Co (ACBM) Income Statement

10 Followers

Acro Biomedical Co Income Statement

Last quarter (Q ), Acro Biomedical Co's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Acro Biomedical Co's net income was $-3.19M. See Acro Biomedical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Sep 19
Total Revenue
-$ 658.50K$ 1.20M$ 687.96K$ 193.54K$ 1.35M
Cost of Revenue
-$ 518.00K$ 938.00K$ 528.56K$ 181.44K$ -1.22M
Gross Profit
-$ 140.50K$ 259.50K$ 159.40K$ 12.10K$ 135.40K
Operating Expense
$ 15.21M$ 16.01M$ 7.95M$ 289.87K$ 434.85K$ -576.95K
Operating Income
$ -15.21M$ -15.87M$ -7.69M$ -130.46K$ -422.75K$ -1.80M
Net Non Operating Interest Income Expense
$ -710.00$ -1.71K$ -4.25K$ -5.08K$ -1.98K$ -2.27K
Other Income Expense
--$ -26.28K$ -52.56K-$ -1.35M
Pretax Income
$ -15.21M$ -15.87M$ -7.70M$ -135.54K$ -424.73K$ -443.82K
Tax Provision
---$ -18.09K$ -53.13K$ -73.07K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -15.20M$ -15.87M$ -7.70M$ -117.45K$ -371.60K$ -370.75K
Basic EPS
--$ -0.14-$ -0.01-
Diluted EPS
--$ -0.14-$ -0.01$ -0.01
Basic Average Shares
--$ 54.98M$ 47.76M$ 47.76M$ 47.76M
Diluted Average Shares
--$ 53.84M$ 47.76M$ 47.76M$ 37.07M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 15.21M$ 16.53M$ 8.89M$ 818.43K$ 616.29K$ -1.80M
Net Income From Continuing And Discontinued Operation
$ -15.21M$ -15.87M$ -7.70M$ -117.45K$ -371.60K$ -370.75K
Normalized Income
$ -3.16M---$ -371.60K-
Interest Expense
----$ 1.98K-
EBIT
$ -15.20M$ -15.87M$ -7.69M$ -130.46K$ -422.75K$ -441.55K
EBITDA
$ 7.56M$ -157.34K$ -42.16K$ -130.46K$ -422.75K$ -441.55K
Currency in USD

Acro Biomedical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis